| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 28 |
| 1 | ACETAMINOPHEN | 19 |
| 2 | PANTOPRAZOLE | 17 |
| 3 | PREDNISONE | 15 |
| 4 | ASPIRIN | 14 |
| 5 | DIPHENHYDRAMINE HYDROCHLORIDE | 14 |
| 6 | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | 14 |
| 7 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 13 |
| 8 | AMLODIPINE BESYLATE | 13 |
| 9 | ASPIRIN 325 MG | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GREEN TEA LEAF | 1 | 0.0250 |
| 1 | DIFLUNISAL | 3 | 0.0037 |
| 2 | HYDROCORTISONE VALERATE | 2 | 0.0032 |
| 3 | HALOBETASOL PROPIONATE | 2 | 0.0015 |
| 4 | NAFCILLIN SODIUM | 1 | 0.0011 |
| 5 | CEFPODOXIME PROXETIL | 1 | 0.0010 |
| 6 | VUTRISIRAN | 3 | 0.0010 |
| 7 | PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION | 1 | 0.0008 |
| 8 | RIVASTIGMINE | 11 | 0.0006 |
| 9 | PILOCARPINE HYDROCHLORIDE | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Loop Diuretic [EPC] | 32 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 21 |
| 2 | Corticosteroid [EPC] | 19 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 14 |
| 4 | Calcium [EPC] | 13 |
| 5 | Expectorant [EPC] | 13 |
| 6 | Aromatase Inhibitor [EPC] | 12 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 12 |
| 8 | Purine Antimetabolite [EPC] | 12 |
| 9 | Cholinesterase Inhibitor [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cholinesterase Inhibitor [EPC] | 11 | 0.0006 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 7 | 0.0004 |
| 2 | Purine Antimetabolite [EPC] | 12 | 0.0001 |
| 3 | Aromatase Inhibitor [EPC] | 12 | 0.0001 |
| 4 | Anti-anginal [EPC] | 1 | 0.0001 |
| 5 | Sulfone [EPC] | 1 | 0.0001 |
| 6 | Calcium [EPC] | 13 | 0.0001 |
| 7 | Loop Diuretic [EPC] | 32 | 0.0001 |
| 8 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 9 | Aldosterone Antagonist [EPC] | 10 | 0.0001 |